285 related articles for article (PubMed ID: 30594231)
1. A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression.
Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Schild SE
Radiat Oncol; 2018 Dec; 13(1):257. PubMed ID: 30594231
[TBL] [Abstract][Full Text] [Related]
2. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.
Rades D; Huttenlocher S; Veninga T; Bajrovic A; Bremer M; Rudat V; Schild SE
Radiat Oncol; 2015 Apr; 10():90. PubMed ID: 25889036
[TBL] [Abstract][Full Text] [Related]
3. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
Rades D; Rudat V; Veninga T; Stalpers LJ; Basic H; Karstens JH; Hoskin PJ; Schild SE
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):905-8. PubMed ID: 18436390
[TBL] [Abstract][Full Text] [Related]
4. High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study.
Rades D; Cacicedo J; Conde-Moreno AJ; Doemer C; Dunst J; Lomidze D; Segedin B; Olbrich D; Holländer NH
BMC Cancer; 2017 Dec; 17(1):818. PubMed ID: 29202720
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
Rades D; Rudat V; Veninga T; Stalpers LJ; Hoskin PJ; Schild SE
Cancer; 2008 Sep; 113(5):1090-6. PubMed ID: 18642349
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Obralic N; Bajrovic A; Rudat V; Schwarz R; Hulshof MC; Poortmans P; Schild SE
J Clin Oncol; 2005 May; 23(15):3366-75. PubMed ID: 15908648
[TBL] [Abstract][Full Text] [Related]
7. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.
Rades D; Panzner A; Rudat V; Karstens JH; Schild SE
Strahlenther Onkol; 2011 Nov; 187(11):729-35. PubMed ID: 22037654
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of metastatic spinal cord compression in very elderly patients.
Rades D; Hoskin PJ; Karstens JH; Rudat V; Veninga T; Stalpers LJ; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):256-63. PubMed ID: 17189074
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
Rades D; Motisi L; Veninga T; Conde-Moreno A; Cacicedo J; Schild SE
Clin Lung Cancer; 2019 Jul; 20(4):322-329. PubMed ID: 31155476
[TBL] [Abstract][Full Text] [Related]
11. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?
Rades D; Walz J; Schild SE; Veninga T; Dunst J
Urology; 2007 Jun; 69(6):1081-5. PubMed ID: 17572191
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)].
Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Alberti W
Strahlenther Onkol; 2005 Sep; 181(9):595-600. PubMed ID: 16170487
[TBL] [Abstract][Full Text] [Related]
13. Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.
Rades D; Huttenlocher S; Šegedin B; Perpar A; Conde AJ; Garcia R; Veninga T; Stalpers LJ; Cacicedo J; Rudat V; Schild SE
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):368-72. PubMed ID: 26232852
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer.
Rades D; Douglas S; Huttenlocher S; Veninga T; Bajrovic A; Rudat V; Schild SE
Strahlenther Onkol; 2012 Dec; 188(12):1114-8. PubMed ID: 23111468
[TBL] [Abstract][Full Text] [Related]
15. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
[TBL] [Abstract][Full Text] [Related]
16. Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients.
Huttenlocher S; Sehmisch L; Rudat V; Rades D
J Dermatol; 2014 Dec; 41(12):1082-6. PubMed ID: 25327333
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer.
Rades D; Stalpers LJ; Veninga T; Rudat V; Schulte R; Hoskin PJ
J Urol; 2006 Feb; 175(2):552-6. PubMed ID: 16406994
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
Freundt K; Meyners T; Bajrovic A; Basic H; Karstens JH; Adamietz IA; Rudat V; Schild SE; Dunst J; Rades D
Strahlenther Onkol; 2010 Apr; 186(4):218-23. PubMed ID: 20354660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
